XBiotech Inc. XBIT Balance Sheet

Xbiotech inc. (XBIT)

Balance Sheet / Yearly

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14
Current assets:
Cash and cash equivalents
241,540	714,594	40,338	44,921	12,019	15,823	20,849	24,849	28,416	31,768	38,977	45,949	54,632	34,324	46,793	64,798	78,225	91,051	105,680	117,382	52,236	57,329
Accounts receivable
9,681	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred cost of goods sold
1,703	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Income tax receivable
3,793	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Prepaid expenses and other current assets
1,179	1,669	573	678	963	1,193	457	917	1,333	1,564	1,312	1,352	2,453	2,606	2,048	1,530	1,614	1,990	1,907	2,971	493	411
Deferred offering costs
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	1,036	324
Total current assets
257,896	716,263	40,911	45,599	12,982	17,016	21,306	25,766	29,749	33,332	40,289	47,301	57,085	36,930	48,841	66,328	79,839	93,041	107,587	120,353	53,765	58,064
Property and equipment, net
25,034	25,171	25,732	26,276	26,842	27,329	27,938	28,524	29,111	29,640	30,382	30,540	30,531	10,142	10,082	9,779	7,715	5,946	4,854	3,813	4,923	3,227
Escrow receivable
75,000	75,000	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred tax asset
443	443	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Building construction in progress
-	-	-	-	-	-	-	-	-	-	0	0	0	19,978	19,369	17,094	13,708	10,371	6,606	2,681	-	886
Total assets
358,373	816,877	66,643	71,875	39,824	44,345	49,244	54,290	58,860	62,972	70,671	77,841	87,616	67,050	78,292	93,201	101,262	109,358	119,047	126,847	58,688	62,177
Current liabilities:
Accounts payable
5,649	2,149	1,061	1,550	1,861	1,653	878	1,455	1,160	1,730	2,225	3,385	2,697	4,431	4,465	8,494	4,846	4,825	3,964	2,285	2,915	1,629
Accrued expenses
1,371	4,180	960	912	980	1,291	1,422	1,301	1,274	1,062	1,277	1,278	2,626	3,532	2,176	1,882	1,717	1,466	994	580	911	1,518
Contract Liabilities
-	4,500	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred revenue
1,500	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Income taxes payable
1,715	49,361	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total current liabilities
10,235	60,190	2,021	2,462	2,841	2,944	2,300	2,756	2,434	2,792	3,502	4,663	5,323	7,963	6,641	10,376	6,563	6,291	4,958	2,865	3,826	3,147
Long-term liabilities:
Deferred rent
-	-	-	-	-	3	7	12	16	18	20	22	23	23	22	21	20	17	12	7	2	0
Income tax payable - non-current
1,056	1,056	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total liabilities
11,291	61,246	2,021	2,462	2,841	2,947	2,307	2,768	2,450	2,810	3,522	4,685	5,346	7,986	6,663	10,397	6,583	6,308	4,970	2,872	3,828	3,147
Shareholders’ equity:
Preferred stock, no par value, unlimited shares authorized, no shares outstanding
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-	0
Common stock, no par value, unlimited shares authorized, 28,852,927 and 41,519,633 shares outstanding at March 31, 2020 and December 31, 2019, respectively
242,942	324,808	320,130	319,045	280,664	279,353	278,879	278,441	277,803	277,492	277,078	276,589	276,079	242,419	238,808	237,523	235,751	233,902	232,850	231,935	156,393	152,351
Accumulated other comprehensive loss
-16	-106	58	-216	-117	-255	-353	-381	-762	-768	-616	-326	166	57	-166	-190	-164	-201	-11	66	-251	-153
Retained earnings
104,156	430,929	-255,566	-249,416	-243,564	-237,700	-231,589	-226,538	-220,631	-216,562	-209,313	-203,107	-193,975	-183,412	-167,013	-154,529	-140,908	-130,651	-118,762	-108,026	-101,282	-93,168
Total shareholders’ equity
347,082	755,631	64,622	69,413	36,983	41,398	46,937	51,522	56,410	60,162	67,149	73,156	82,270	59,064	71,629	82,804	94,679	103,050	114,077	123,975	54,860	59,030
Total liabilities and shareholders’ equity
358,373	816,877	66,643	71,875	39,824	44,345	49,244	54,290	58,860	62,972	70,671	77,841	87,616	67,050	78,292	93,201	101,262	109,358	119,047	126,847	58,688	62,177